MedPath

Quest Sound Recover (SR2) vs. Venture SR2

Not Applicable
Completed
Conditions
Hearing Loss
Interventions
Device: hearing aid
Registration Number
NCT02895477
Lead Sponsor
Sonova AG
Brief Summary

Goal of this study is to determine the benefit of an improved feature on a new hearing aid platform.

To investigate the improvements of this feature is compared on a new and older hearing aid platform. The obtained results will be used for future improvement for this feature. This feature should improve the speech understanding and speech recognition of the hearing aid user.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Ability to fill in a question conscientious
  • Healthy outer ear (w/o previous surgical procedures)
  • Sensorineural symmetric hearing loss (HL)
  • N4 to N7 (degree of HL)
Exclusion Criteria
  • Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product,
  • Limited mobility and not in the position to attend weekly appointments
  • Limited ability to describe listening impressions/experiences and the use of the hearing aid
  • Inability to produce a reliable hearing test result when pure tone audiometry is attempted by the audiologist
  • Massively limited dexterity
  • Known Psychological problems
  • Central hearing problems

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Test grouphearing aidHearing aid
Intervention grouphearing aidHearing aid
Primary Outcome Measures
NameTimeMethod
Functional gainafter 8 weeks

Functional gain is to measure the aided threshold (in dB hearing level \[HL\]) in free field via loudspeaker.

Phoneme Perception Testafter 8 weeks

Change of detection thresholds after 4 weeks hearing instrument wearing time

Secondary Outcome Measures
NameTimeMethod
sound quality ratingsafter 6 and 12 weeks
questionnairesafter 2, 6, 8 and 12 weeks

Trial Locations

Locations (1)

Sonova AG

🇨🇭

Stäfa, Zürich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath